661 abstracts found.



Results filter

Living with and beyond cancer top research priorities in the UK – priority setting partnership

Year:

Session type:

Feng Li1,Ian Lewis1,Adrienne Morgan2,Angela McCullagh1,Anne Johnson3,Ceinwen Giles4,Diana Greenfield5,Graeme Crawford6,Jacqui Gath2,Jane Lyons7,Jervoise Andreyev8,Jonathan Tobutt9,Julia Tugwell1,Karen Robb10,Laura Cove-Smith11,Lindsey Bennister12,Natalie Doyle13,Nicolas Lee14,Rebecca Nash14,Richard Simcock15,Richard Stephens1,Sabine Best16,Stuart Griffiths1,Susan Moug17,Sandra Regan18,Patricia Ellis18

1National Cancer Research Institute,2Independent Cancer Patients’ Voice,3Velindre NHS Trust,4Shine Cancer Support,5Sheffield Teaching Hospitals NHS Foundation Trust,6Bangor Health Centre,7Cancer 52,8United Lincolnshire Hospitals NHS Trust,9Kirkwood Hospice, Huddersfield,10Transforming Cancer Services Team in London,11The Christie NHS Foundation Trust,12Sarcoma UK,13The Royal Marsden NHS Foundation Trust,14Macmillan Cancer Support,15Brighton and Sussex University Hospital Trust,16Marie Curie,17Royal Alexandra Hospital Paisley, NHS Greater Glasgow and Clyde,18The James Lind Alliance


Investigating causal relationships between sleep characteristics and risk of breast cancer: a Mendelian randomization study

Year:

Session type:

Rebecca Richmond1,Emma Anderson1,Hassan Dashti2,Samuel Jones3,Jacqueline Lane2,Caroline Relton1,Marcus Munafò4,Debbie Lawlor1,Martin Rutter5,Richa Saxena2,Mike Weedon3,Richard Martin1,George Davey Smith1

1University of Bristol,2Massachusetts General Hospital, Boston,3University of Exeter,4University of Bristol, UK,5University of Manchester


E-cigarettes as a Smoking Cessation aid in Cancer Patients: Health Professionals knowledge, attitude and current practice

Year:

Session type:

Jo Brett1,Fiona Matley2,Emma Davies1,Paul Aveyard3,Mary Wells4,David Foxcroft1,Brian Nicholson3,Lesley Sinclair5,Shiroma De Silva Minor6,Sarah Jakes7,Eila Watson1

1Oxford Brookes University,2Oxford Brooke University,3University of Oxford,4Imperial College Healthcare NHS Trust,5University of Stirling,6Oxford University Hospitals NHS Trust,7New Nicotine Alliance


Effective chemoprevention strategies in APC driven mouse models of intestinal tumourigenesis

Year:

Session type:

Michael Hodder1,Patrizia Cammareri1,Dennis Timmerman1,Owen Sansom1

1CRUK Beatson Institute


Recurrence rates after low dose radioiodine ablation for differentiated thyroid cancer within the NCRI HiLo trial.

Year:

Session type:

Jon Wadsley1,Hakim-Moulay Dehbi2,Ujjal Mallick3,Kate Newbold4,Clive Harmer5,Allan Hackshaw2

1Weston Park Hospital,2University College London, UK,3Freeman Hospital, Newcastle upon Tyne, UK,4Royal Marsden Hospital, Sutton, UK,5Formerly of the Royal Marsden Hospital, Sutton


Evaluating the trade-offs men with localised prostate cancer make between the risks and benefits of treatments: The COMPARE study

Year:

Session type:

Hashim U. Ahmed1,Verity Watson2,Neil McCartan3,Nicolas Krucien2,Victor Abu4,Divine Ikenwilo2,Mark Emberton3

1Imperial College London,2Health Economics Research Unit, University of Aberdeen,3Research Department of Urology, Division of Surgery and Interventional Science, Faculty of Medicine, University College London,4Health and Social Care, Adult Nursing, London South Bank University


Trends in mortality from malignant melanoma: an observational study of the World Health Organisation mortality database from 1985 to 2015

Year:

Session type:

Dorothy Yang1,Justin Salciccioli2,Dominic Marshall3,Joseph Shalhoub4

1Royal Free London NHS Foundation Trust,2Department of Medicine, Mount Auburn Hospital,3Oxford University Clinical Academic Graduate School, John Radcliffe Hospital,4Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London


Molecular archaeology of cancer

Year:

Session type:

Peter Van Loo1,2

1The Francis Crick Institute, London, UK,2University of Leuven, Leuven, Belgium


European Cancer Incidence is Significantly Reduced in Huntington’s Disease Patients – Unravelling it’s Protective Mechanisms.

Year:

Session type:

Paul McNulty1,Raviram Ramesh1,Richard Pilcher1,Renata Neciunaite1,Lesley Jones1,Alys Hughes1,Daniel Farewell1,Timothy Stone1,Peter Holmes1

1Cardiff University


Precision oncology

Year:

Session type:

Sandesh Kc1,Thomas King2,David Mak2,Rupesh Bhatt2,Alan Doherty2,Richard Viney2,Prashant Patel2,Brian Kelly2

1University Hospital Birmingham,2UHB


Molecular Imaging of Immunotherapies

Year:

Session type:

Sanjiv Gambhir1
1Stanford university

Applying genetic information to prevent colorectal cancer

Year:

Session type:

Malcolm Dunlop1
1University of Esinburgh

Co-existing Tumour-Immune Microenvironments in Advanced Ovarian Cancer

Year:

Session type:

Martin Miller1
1University of Cambridge

T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumour immunity.

Year:

Session type:

Marta Canel1,David Taggart1,Norbert Kraut2,Irene C. Waizenegger2,Alan Serrels1
1University of Edinburgh,2boehringer-ingelheim

Adipocytes in the melanoma microenvironment

Year:

Session type:

Richard White1
1Memorial Sloan-Kettering Cancer Center

Transcriptomic data reveal the prognostic and biological significance of the Vitamin D Receptor (VDR) via pro-immune and anti-proliferative mechanisms in a cohort of 703 primary melanomas

Year:

Session type:

Sathya Muralidhar1,Julia Newton-Bishop1,Timothy Bishop1,David Adams2,Louise Van Der Weyden2,Jeremie Nsengimana1,Jonathan Laye1,Juliette Randerson-Moor1,Joanna Pozniak1,Joey Mark Diaz1
1University of Leeds,2Wellcome Sanger Institute

Precision medicine for melanoma: are we there yet?

Year:

Session type:

Richard Marais1
1CR-UK Manchester Institute

Options and Opportunities for Health Data Science

Year:

Session type:

Andrew Morris1
1Health Data Research UK

Mining genomic data to inform cancer prevention &  treatment strategies

Year:

Session type:

Richard Martin1
1University of Bristol

Multimorbidity in primary care: implications for cancer prevention, diagnosis and support

Year:

Session type:

David Blane1
1University of Glasgow

Understanding the role of multimorbidity on symptomatic presentation and early diagnosis of cancer

Year:

Session type:

Katriina Whitaker1
1University of Surrey

Quantifying under-treatment in older adult lung cancer patients in Northern Ireland

Year:

Session type:

Abdulqadr Akinoso-Imran1,Finian Bannon1
1Queen's University Belfast

Investigating common comorbidities in patients diagnosed with cancer– a Scottish Routes from Diagnosis analysis

Year:

Session type:

Eilidh Fletcher1,Cheryl Denny1,Kelly Shiell-Davis2
1Information Services Division, NHS National Services Scotland,2Macmillan Cancer Support

NHS Cancer Strategy

Year:

Session type:

David Fitzgerald1
1NHS England

Pre-clinical models of glioblastoma that enable more accurate evaluation of new treatment combinations

Year:

Session type:

Anthony Chalmers1
1Glasgow Centre for Cancer Research

Why is cancer so difficult?

Year:

Session type:

Martin Christlieb1
1University of Oxford

De-mystifying today’s science

Year:

Session type:

Elaine Vickers1
1Science Communicated

Why is behaviour change so difficult?

Year:

Session type:

Theresa Marteau1
1University of Cambridge

GvHD: uncoupling immunopathology from the graft-vs-leukemia effect.

Year:

Session type:

Burkhard Becher1
1University of Zurich

A personalised approach to treating patients with haematological malignancies

Year:

Session type:

Susanne Saussele1
1Universitätsmedizin Mannheim

Clone Wars in Leukaemia: Are there lessons for all cancers?

Year:

Session type:

Paresh Vyas1
1University of Oxford

Tumor-educated platelets for the detection and monitoring of cancer

Year:

Session type:

Thomas Wurdinger1
1VU University Medical Center

Use and safety of novel alternative nicotine delivery devices: a role for cancer harm reduction?

Year:

Session type:

Lion Shahab1
1University College London

Air pollution and cancer

Year:

Session type:

John Cherrie1
1Heriot Watt University and the Institute of Occupational Medicine

Carbon Nanotubes may pose Asbestos-style Cancer Risk

Year:

Session type:

Marion MacFarlane1
1MRC Toxicology Unit, University of Cambridge

FOS/FOSB rearrangements; defining the human bone tumour, osteoblastoma

Year:

Session type:

Matthew Fittall1,Nischalan Pillay2,Anna-Christina Strobl3,Annelien Verfaillie1,Jonas Demeulemeester1,Maxime Tarabichi4,Matthew Young5,Agamemnon Grigoriadis6,Peter Van Loo4,Peter Campbell5,Adrienne Flanagan2,Sam Behjati7
1The Francis Crick Institute,2University College London,3Royal National Orthopaedic Hospital,4The Francis Crick Institure,5Wellcome Trust Sanger Institure,6King's College London,7Wellcome Trust Sanger Institute

Circulating tumour DNA as a tool to guide clinical decision making in melanoma

Year:

Session type:

Rebecca Lee1
1CRUK MI

Polyphenols Act Synergistically with Doxorubicin and Etoposide in Leukemia Cell Lines.

Year:

Session type:

Amani Mahbub1,Nicola Jordan-Mahy2,Neil Cross2,Christine Le Maitre2,Sarah Haywood-Small2
1Umm Al Qura University,2Sheffield Hallam University

From rarity to clarity: gd T cells in cancer

Year:

Session type:

Seth Coffelt1
1Beatson Institute for Cancer Research

Antibody Tumour Targeting Is Enhanced by CD27 Agonists through Myeloid Recruitment

Year:

Session type:

Sean Lim1
1University of Southampton

Identifying the early cancerous body

Year:

Session type:

Rikke Sand Anderson1
1Aarhus University

Molecular mechanisms underlying phenotypic plasticity in malignant glioma

Year:

Session type:

Costanza Lo Cascio1,Ernesto Luna1,Rohit Khurana1,Roberto Fiorelli1,Shwetal Mehta1
1Barrow Neurological Institute

Exploring genomic medicine at the interface of cancer research and clinical care

Year:

Session type:

Anne Kerr1
1University of Leeds

People Like You: Genomics in a London breast cancer service

Year:

Session type:

Sophie Day1
1Goldsmiths University, London

Myeloid cells in the ovarian cancer microenvironment

Year:

Session type:

Fran Balkwill1
1Barts Cancer Institute

Macrophages: Bad Actors in Cancer

Year:

Session type:

Jeffrey Pollard1
1The University of Edinburgh

Early pancreatic cancer diagnostics

Year:

Session type:

Stephen Pereira1
1University College London

Identifying and interpreting robust genetic dependencies in cancer cell lines

Year:

Session type:

Colm Ryan1
1University College Dublin

Applying genomics to tailor colorectal cancer screening in primary care

Year:

Session type:

Jon Emery1
1Centre for Cancer Research and Department of General Practice, University of Melbourne

New approaches in the diagnosis of lung cancer – from bench to primary care

Year:

Session type:

Richard Neal1
1University of Leeds